A range of universal dMMR tumour testing strategies for identifying Lynch syndrome in people with incident colorectal cancer (CRC) are likely to be cost-effective in Australia. The conclusion, from a Cancer Council NSW evaluation of systematic Lynch syndrome testing, assumes a willingness-to-pay threshold of $30,000-$50,000 per life-year saved. The study, published in the MJA, modelled ...
Lynch syndrome testing finds more support
By Mardi Chapman
31 Oct 2019